Scantox appoints Andy Brown as Group Chief Commercial Officer
July 7th – Scantox Group, a leading provider of nonclinical services in Europe, has named Andy Brown as Group Chief Commercial Officer with the overall responsibility of growing sales within toxicology, discovery and lab services and fostering positive relationships with current and prospective clients. Together with the executive management team and Impilo, Andy will be part of Scantox Group overall strategy of driving the organic and inorganic growth of Scantox.
“We will continue to focus our efforts on doing the things that customers value most while enhancing our preclinical services